In the past decade or so, the number of medications approved to treat ulcerative colitis (UC) has increased. But because the drugs haven’t been around long, we don’t have many details about the people taking them, how people respond to treatments in the real world, or how newer therapie...

If you have Crohn’s disease or ulcerative colitis, infusion therapy may become part of your treatment regimen to manage your disease. There are many ways you can receive your infusion therapy – read on to learn more about how infusion therapy may be used to treat IBD, your options for w...

If you have Crohn’s disease or ulcerative colitis, then you know how hard it can be to pay for your medication. A Foundation study found that people with inflammatory bowel disease (IBD), especially Crohn’s, pay three times the total health care costs and double the out-of-pocket expens...

Ever wonder what fecal microbiota transplantation is? Check out our latest vlog featuring Dr. Neil Nandi, Director of the Inflammatory Bowel Disease Center at Drexel University, College of Medicine. Video Length ...

On May 30th of this year, the Food and Drug Administration (FDA) approved a new treatment for moderately to severely active ulcerative colitis.  Tofacitinib, which is made by Pfizer Labs, was previously approved in 2012 for rheumatoid arthritis and in 2017 for psoriatic arthritis. The ...